Hjem › Akut lymfoblastisk leukemi › California › Los Angeles
Kliniske studier for Akut lymfoblastisk leukemi i Los Angeles, CA
14 studier for Akut lymfoblastisk leukemi søker deltakere på steder i og rundt Los Angeles (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
A Multicenter Study to Evaluate Next-Generation Sequencing (NGS) Testing and Monitoring of B-Cell Recovery to Guide Management Following Chimeric Antigen Receptor T-cell (CART) Induced Remission in Children and Young Adults With B Lineage Acute Lymph...
Rekrutterer
- Children's Hospital of Los Angeles, Los Angeles
A Phase 2 Study of WU-CART-007, an Anti-CD7 Allogeneic CAR-T Cell Therapy in T-Cell Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma (T-RRex)
RekruttererFase 2
- Children's Hospital Los Angeles, Los Angeles
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
RekruttererFase 1/2
- Children's Hospital Los Angeles, Los Angeles
Caloric Restriction and Activity to Reduce Chemoresistance in B-ALL
RekruttererFase 2
- Children's Hospital Los Angeles, Los Angeles
Safety Study to Evaluate the Occurrence of EFAD in Pediatric Patients With PNAC Who Require More Than Eight Weeks of Omegaven Treatment
RekruttererObservasjonsstudie
- University of California Los Angeles, Los Angeles
Feasibility and Safety of Collecting and Combining Autologous Hematopoietic Stem Cells With Chimeric Antigen Receptor (CAR) T-Cell Therapy in Subjects With Relapsed/Refractory Hematological Malignancies
RekruttererFase 1
- Cedars-Sinai Medical Center, Los Angeles
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
RekruttererObservasjonsstudie
- UCLA, Los Angeles
TINI 2: Total Therapy for Infants With Acute Lymphoblastic Leukemia II
RekruttererFase 1/2
- Children's Hospital Los Angeles, Los Angeles
Pharmacogenomics of Asparaginase Induced Hepatotoxicity
RekruttererObservasjonsstudie
- Los Angeles General Medical Center, Los Angeles
- USC / Norris Comprehensive Cancer Center, Los Angeles
A Study of Olverembatinib in Patients With Newly Diagnosed Ph+ ALL (POLARIS-1)
RekruttererFase 3
- Ascentage Investigative Site #1134, Los Angeles
- Ascentage Investigative Site #1059, Los Angeles
Asparaginase Erwinia Chrysanthemi With Chemotherapy for the Treatment of High-Risk Adults With Newly Diagnosed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma
RekruttererFase 2
- UCLA / Jonsson Comprehensive Cancer Center, Los Angeles
Bright Ideas - CIN Feasibility Study
Rekrutterer
- Children's Hospital Los Angeles, Los Angeles
Using Augmented Reality to Promote Physical Activity in Children With Cerebral Palsy
Rekrutterer
- Jackie and Gene Autry Orthopedic Center, CHLA, Los Angeles
Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies
RekruttererFase 1
- Children's Hospital Los Angeles, Los Angeles
Akut lymfoblastisk leukemi-studier i andre byer
- Houston, TX28 studier
- New York City, NY23 studier
- Seattle, WA21 studier
- Baldwin Park, CA21 studier
- Chicago, IL20 studier
- Atlanta, GA19 studier
- Memphis, TN16 studier
- Washington, DC16 studier
- Philadelphia, PA16 studier
- Boston, MA15 studier
- Mountain View, CA13 studier
- Durham, NC13 studier
Andre studier i Los Angeles
- Ikke-småcellet lungekreft87 studier
- Kreft (alle typer)74 studier
- Brystkreft73 studier
- Prostatakreft61 studier
- Kolorektal kreft59 studier
- Metastatisk kreft57 studier
- Eggstokkreft50 studier
- Lungekreft45 studier
- Plateepitelcancer i hode og hals42 studier
- Pankreaskreft35 studier
- Endometriekreft34 studier
- Melanom34 studier
Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.